Covid: India's 1st Strain-Specific Vaccine Targeting Omicron Is In Sight

Sinhaajay397@gmail.c25 Jan, 2022News

India could soon have its first messenger or mRNA vaccine soon have its first messenger or mRNA vaccine soon, with the near-completion of Phase 3 clinical trials by Gennova Biopharmaceuticals, even as the company also started developing a variant or Omicron-specific vaccine using the same tech platform. The Pune firm has recently submitted Phase 2 trial data of their two-dose mRNA vaccine, and is close to completing phase 3 trials (over 3000 of the 4000 subjects have received the 2nd dose), sources told TOI. It has started manufacturing the vaccine "at risk" and can roll out "sufficient" quantities once it gets the regulatory nod. India's drug regulator is expected to review the data this week and take a decision regarding the approval soon, official sources said.